Trial Profile
A Randomized Clinical Trial of Efficacy and Safety on the Use of Belatacept as Compared to Tacrolimus in the Setting of Rabbit Antithymocyte Globulin Induction and Rapid Steroid Discontinuation in Deceased Donor Renal Transplant Recipients With a Focus on Ameliorating Delayed Graft Function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Belatacept (Primary) ; Antithymocyte globulin; Methylprednisolone; Mycophenolate; Tacrolimus
- Indications Renal transplant rejection
- Focus Therapeutic Use
- 05 Feb 2018 Status changed from recruiting to completed.
- 04 Jul 2014 New trial record